<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37090451</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1885-642X</ISSN><JournalIssue CitedMedium="Print"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Season>Jan-Mar</Season></PubDate></JournalIssue><Title>Pharmacy practice</Title><ISOAbbreviation>Pharm Pract (Granada)</ISOAbbreviation></Journal><ArticleTitle>Association between COVID-19 symptoms, COVID-19 vaccine, and somatization among a sample of the Lebanese adults.</ArticleTitle><Pagination><StartPage>2763</StartPage><MedlinePgn>2763</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2763</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.18549/PharmPract.2023.1.2763</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">Long COVID syndrome, the poorly defined illness, has been increasingly mentioned in recent studies yet is still poorly understood especially when it comes to precipitating and modulating factors, the high prevalence of mental health problems associated with the COVID-19 pandemic has brought to light the hypothesis of the existence of a psychological component associated with the persistence of symptoms and if vaccination may serve as a modulating factor. This study aims to examine the prevalence of somatization disorders and association between persistent COVID-19 symptoms and COVID-19 vaccine with somatization among a sample of the Lebanese general population.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A cross-sectional study was carried out between September and October 2021. The snowball sampling technique was picked to choose a sample that addressed all Lebanese Mohafazat. Patient Health Questionnaire-15 (PHQ-15) was used to assess somatization.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 403 participants was enrolled in this study, with a mean age of 32.76 &#xb1; 13.24 years, 108 (26.8%) had medium somatization symptoms (PHQ-15 scores &#x2265;10). Having persistent COVID symptoms (&#x3b2;=2.15) was significantly associated with more somatization, whereas the intake of COVID vaccine (&#x3b2;=-1.17) was significantly associated with less somatization.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Long lasting COVID-19 symptoms were closely related to somatization, although the administration of the COVID-19 vaccine was associated with less somatization. However, further studies are needed to provide a better understanding of the relationship between long COVID and somatization, on one hand, and the modulating factors on the other hand.</AbstractText><CopyrightInformation>Copyright: &#xa9; Pharmacy Practice.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nehme</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2805-3222</Identifier><AffiliationInfo><Affiliation>School of Medicine and Medical Sciences, Holy Spirit University of Kaslik, P.O. Box 446, Jounieh, Lebanon. antonio.j.nehme@net.usek.edu.lb.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barakat</LastName><ForeName>Muna</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7966-1172</Identifier><AffiliationInfo><Affiliation>Department of Clinical Pharmacy and therapeutics, Faculty of Pharmacy, Applied Science Private University, Amman, 11931, Jordan. m_barakat@asu.edu.jo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malaeb</LastName><ForeName>Diana</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2436-850X</Identifier><AffiliationInfo><Affiliation>College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates. Dr.diana@gmu.edu.ae.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obeid</LastName><ForeName>Sahar</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0735-4704</Identifier><AffiliationInfo><Affiliation>Social and Education Sciences Department, School of Arts and Sciences, Lebanese American University, Jbeil, Lebanon. saharobeid23@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hallit</LastName><ForeName>Souheil</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6918-5689</Identifier><AffiliationInfo><Affiliation>School of Medicine and Medical Sciences, Holy Spirit University of Kaslik, P.O. Box 446, Research Department, Psychiatric Hospital of the Cross, Jal Eddib, Lebanon. souheilhallit@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haddad</LastName><ForeName>Georges</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-2981-4572</Identifier><AffiliationInfo><Affiliation>School of Medicine and Medical Sciences, Holy Spirit University of Kaslik, P.O. Box 446, Psychiatry Departments, Psychiatric Hospital of the Cross, Jal Eddib, Lebanon. georgeshaddad.hpc@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Pharm Pract (Granada)</MedlineTA><NlmUniqueID>101530029</NlmUniqueID><ISSNLinking>1885-642X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID 19</Keyword><Keyword MajorTopicYN="N">COVID persistent symptoms</Keyword><Keyword MajorTopicYN="N">Lebanon</Keyword><Keyword MajorTopicYN="N">somatization</Keyword><Keyword MajorTopicYN="N">somatoform disorders</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>3</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37090451</ArticleId><ArticleId IdType="pmc">PMC10117341</ArticleId><ArticleId IdType="doi">10.18549/PharmPract.2023.1.2763</ArticleId><ArticleId IdType="pii">pharmpract-21-2763</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>1. LIPOWSKI ZJ. Somatization:the concept and its clinical application. The American Journal of Psychiatry. 1988;145(11):1358-1368. https://doi.org/10.1176/ajp.145.11.1358</Citation><ArticleIdList><ArticleId IdType="pubmed">3056044</ArticleId></ArticleIdList></Reference><Reference><Citation>LIPOWSKI ZJ. Somatization:the concept and its clinical application. The American Journal of Psychiatry. 1988;145(11):1358&#x2013;1368. doi: 10.1176/ajp.145.11.1358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/ajp.145.11.1358</ArticleId><ArticleId IdType="pubmed">3056044</ArticleId></ArticleIdList></Reference><Reference><Citation>2. Jadhakhan F, Lindner O, Blakemore A, et al. Prevalence of medically unexplained symptoms in adults who are high users of health care services:a systematic review and meta-analysis protocol. BMJ Open. 2019;9(7). https://doi.org/10.1136/bmjopen-2018-027922</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6609118</ArticleId><ArticleId IdType="pubmed">31270115</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadhakhan F, Lindner O, Blakemore A, et al. Prevalence of medically unexplained symptoms in adults who are high users of health care services:a systematic review and meta-analysis protocol. BMJ Open. 2019;9(7) doi: 10.1136/bmjopen-2018-027922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-027922</ArticleId><ArticleId IdType="pmc">PMC6609118</ArticleId><ArticleId IdType="pubmed">31270115</ArticleId></ArticleIdList></Reference><Reference><Citation>3. D'Souza RS, Hooten WM. Somatic Syndrome Disorders. StatPearls Treasure Island (FL):StatPearls Publishing;2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Souza RS, Hooten WM. Somatic Syndrome Disorders. StatPearls Treasure Island (FL): StatPearls Publishing; 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>4. Garrusi B, Danaei M, Aboosaeidi R. The prevalence and predictive factors of somatization and its relationship with anxiety and depression in Iranian population. J Prev Med Hyg. 2019;60(4):E400-E406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6953450</ArticleId><ArticleId IdType="pubmed">31967099</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrusi B, Danaei M, Aboosaeidi R. The prevalence and predictive factors of somatization and its relationship with anxiety and depression in Iranian population. J Prev Med Hyg. 2019;60(4):E400&#x2013;E406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6953450</ArticleId><ArticleId IdType="pubmed">31967099</ArticleId></ArticleIdList></Reference><Reference><Citation>5. Keskin G. Approach to stress endocrine response:somatization in the context of gastroenterological symptoms:a systematic review. Afr Health Sci. 2019;19(3):2537-2545. https://doi.org/10.4314/ahs.v19i3.29</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7040288</ArticleId><ArticleId IdType="pubmed">32127826</ArticleId></ArticleIdList></Reference><Reference><Citation>Keskin G. Approach to stress endocrine response:somatization in the context of gastroenterological symptoms:a systematic review. Afr Health Sci. 2019;19(3):2537&#x2013;2545. doi: 10.4314/ahs.v19i3.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/ahs.v19i3.29</ArticleId><ArticleId IdType="pmc">PMC7040288</ArticleId><ArticleId IdType="pubmed">32127826</ArticleId></ArticleIdList></Reference><Reference><Citation>6. Somatic symptom disorder. Mayo Clinic Health Information Library:Diseases and Conditions. 2020.</Citation></Reference><Reference><Citation>Somatic symptom disorder. Mayo Clinic Health Information Library:Diseases and Conditions. 2020</Citation></Reference><Reference><Citation>7. Escalona R, Achilles G, Waitzkin H, et al. PTSD and Somatization in Women Treated at a VA Primary Care Clinic. Psychosomatics. 2004;45(4):291-296. https://doi.org/10.1176/appi.psy.45.4.291</Citation><ArticleIdList><ArticleId IdType="pubmed">15232042</ArticleId></ArticleIdList></Reference><Reference><Citation>Escalona R, Achilles G, Waitzkin H, et al. PTSD and Somatization in Women Treated at a VA Primary Care Clinic. Psychosomatics. 2004;45(4):291&#x2013;296. doi: 10.1176/appi.psy.45.4.291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.psy.45.4.291</ArticleId><ArticleId IdType="pubmed">15232042</ArticleId></ArticleIdList></Reference><Reference><Citation>8. Stewart DE. The Changing Faces of Somatization. Psychosomatics. 1990;31(2):153-158. https://doi.org/10.1016/s0033-3182(90)72188-3</Citation><ArticleIdList><ArticleId IdType="pubmed">2330395</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart DE. The Changing Faces of Somatization. Psychosomatics. 1990;31(2):153&#x2013;158. doi: 10.1016/s0033-3182(90)72188-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0033-3182(90)72188-3</ArticleId><ArticleId IdType="pubmed">2330395</ArticleId></ArticleIdList></Reference><Reference><Citation>9. WHO Coronavirus (COVID-19) Dashboard. Available at:https://covid19.who.int. Accessed Jan 15, 2022.</Citation></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard.  [Accessed Jan 15 2022].  Available at: https://covid19.who.int .</Citation></Reference><Reference><Citation>10. Coronavirus Disease 2019 (COVID-19) &#x2013;Symptoms. 2021;Available at:https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html. Accessed Jan 15, 2022.</Citation></Reference><Reference><Citation>Coronavirus Disease 2019 (COVID-19) &#x2013;Symptoms. 2021.  [Accessed Jan 15 2022].  Available at: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html .</Citation></Reference><Reference><Citation>11. Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network &#x2014;United States, March&#x2013;June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-998. https://doi.org/10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network &#x2014;United States, March&#x2013;June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>12. Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors:A Mediterranean cohort study. J Infect. 2021;82(3):378-383. https://doi.org/10.1016/j.jinf.2021.01.004</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors:A Mediterranean cohort study. J Infect. 2021;82(3):378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>13. Sallam M, Al-Sanafi M, Sallam M. A Global Map of COVID-19 Vaccine Acceptance Rates per Country:An Updated Concise Narrative Review. J Multidiscip Healthc. 2022;15:21-45. https://doi.org/10.2147/jmdh.s347669</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8760993</ArticleId><ArticleId IdType="pubmed">35046661</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallam M, Al-Sanafi M, Sallam M. A Global Map of COVID-19 Vaccine Acceptance Rates per Country:An Updated Concise Narrative Review. J Multidiscip Healthc. 2022;15:21&#x2013;45. doi: 10.2147/jmdh.s347669.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/jmdh.s347669</ArticleId><ArticleId IdType="pmc">PMC8760993</ArticleId><ArticleId IdType="pubmed">35046661</ArticleId></ArticleIdList></Reference><Reference><Citation>14. Khoury P, Azar E, Hitti E. COVID-19 Response in Lebanon:Current Experience and Challenges in a Low-Resource Setting. JAMA. 2020;324(6):548-549. https://doi.org/10.1001/jama.2020.12695</Citation><ArticleIdList><ArticleId IdType="pubmed">32722763</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury P, Azar E, Hitti E. COVID-19 Response in Lebanon:Current Experience and Challenges in a Low-Resource Setting. JAMA. 2020;324(6):548&#x2013;549. doi: 10.1001/jama.2020.12695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12695</ArticleId><ArticleId IdType="pubmed">32722763</ArticleId></ArticleIdList></Reference><Reference><Citation>15. Lindert J, Jakubauskiene M, Bilsen J. The COVID-19 disaster and mental health&#x2014;assessing, responding and recovering. European Journal of Public Health. 2021;31(Supplement_4):iv31-iv35. https://doi.org/10.1093/eurpub/ckab153</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576295</ArticleId><ArticleId IdType="pubmed">34751367</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindert J, Jakubauskiene M, Bilsen J. The COVID-19 disaster and mental health&#x2014;assessing, responding and recovering. European Journal of Public Health. 2021;31(Supplement_4):iv31&#x2013;iv35. doi: 10.1093/eurpub/ckab153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckab153</ArticleId><ArticleId IdType="pmc">PMC8576295</ArticleId><ArticleId IdType="pubmed">34751367</ArticleId></ArticleIdList></Reference><Reference><Citation>16. Cheaito MA, Al-Hajj S. A brief report on the Beirut port explosion. Mediterranean Journal of Emergency Medicine &amp;Acute Care. 2020;1(4). https://doi.org/10.52544/2642-7184(1)4001</Citation></Reference><Reference><Citation>Cheaito MA, Al-Hajj S. A brief report on the Beirut port explosion. Mediterranean Journal of Emergency Medicine &amp;Acute Care. 2020;1(4) doi: 10.52544/2642-7184(1)4001.</Citation><ArticleIdList><ArticleId IdType="doi">10.52544/2642-7184(1)4001</ArticleId></ArticleIdList></Reference><Reference><Citation>17. Farran N. Mental health in Lebanon:Tomorrow's silent epidemic. Ment Health Prev. 2021;24:200218. https://doi.org/10.1016/j.mhp.2021.200218</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8503814</ArticleId><ArticleId IdType="pubmed">34660191</ArticleId></ArticleIdList></Reference><Reference><Citation>Farran N. Mental health in Lebanon:Tomorrow's silent epidemic. Ment Health Prev. 2021;24:200218. doi: 10.1016/j.mhp.2021.200218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mhp.2021.200218</ArticleId><ArticleId IdType="pmc">PMC8503814</ArticleId><ArticleId IdType="pubmed">34660191</ArticleId></ArticleIdList></Reference><Reference><Citation>18. Karam EG, Karam GE, Farhat C, et al. Determinants of treatment of mental disorders in Lebanon:barriers to treatment and changing patterns of service use. Epidemiol Psychiatr Sci. 2018;28(6):655-661. https://doi.org/10.1017/s2045796018000422</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6998990</ArticleId><ArticleId IdType="pubmed">30101735</ArticleId></ArticleIdList></Reference><Reference><Citation>Karam EG, Karam GE, Farhat C, et al. Determinants of treatment of mental disorders in Lebanon:barriers to treatment and changing patterns of service use. Epidemiol Psychiatr Sci. 2018;28(6):655&#x2013;661. doi: 10.1017/s2045796018000422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s2045796018000422</ArticleId><ArticleId IdType="pmc">PMC6998990</ArticleId><ArticleId IdType="pubmed">30101735</ArticleId></ArticleIdList></Reference><Reference><Citation>19. Melki IS, Beydoun HA, Khogali M, et al. Household crowding index:a correlate of socioeconomic status and inter-pregnancy spacing in an urban setting. Journal of Epidemiology and Community Health. 2004;58(6):476-480. https://doi.org/10.1136/jech.2003.012690</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1732777</ArticleId><ArticleId IdType="pubmed">15143115</ArticleId></ArticleIdList></Reference><Reference><Citation>Melki IS, Beydoun HA, Khogali M, et al. Household crowding index:a correlate of socioeconomic status and inter-pregnancy spacing in an urban setting. Journal of Epidemiology and Community Health. 2004;58(6):476&#x2013;480. doi: 10.1136/jech.2003.012690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech.2003.012690</ArticleId><ArticleId IdType="pmc">PMC1732777</ArticleId><ArticleId IdType="pubmed">15143115</ArticleId></ArticleIdList></Reference><Reference><Citation>20. Kroenke K, Spitzer RL, Williams JBW. The PHQ-15:Validity of a New Measure for Evaluating the Severity of Somatic Symptoms. Psychosomatic Medicine. 2002;64(2):258-266. https://doi.org/10.1097/00006842-200203000-00008</Citation><ArticleIdList><ArticleId IdType="pubmed">11914441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW. The PHQ-15:Validity of a New Measure for Evaluating the Severity of Somatic Symptoms. Psychosomatic Medicine. 2002;64(2):258&#x2013;266. doi: 10.1097/00006842-200203000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006842-200203000-00008</ArticleId><ArticleId IdType="pubmed">11914441</ArticleId></ArticleIdList></Reference><Reference><Citation>21. Kroenke K, Spitzer RL, Williams JBW, et al. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales:a systematic review. General Hospital Psychiatry. 2010;32(4):345-359. https://doi.org/10.1016/j.genhosppsych.2010.03.006</Citation><ArticleIdList><ArticleId IdType="pubmed">20633738</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW, et al. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales:a systematic review. General Hospital Psychiatry. 2010;32(4):345&#x2013;359. doi: 10.1016/j.genhosppsych.2010.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2010.03.006</ArticleId><ArticleId IdType="pubmed">20633738</ArticleId></ArticleIdList></Reference><Reference><Citation>22. Sawaya H, Atoui M, Hamadeh A, et al. Adaptation and initial validation of the Patient Health Questionnaire &#x2013;9 (PHQ-9) and the Generalized Anxiety Disorder &#x2013;7 Questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample. Psychiatry Research. 2016;239:245-252. https://doi.org/10.1016/j.psychres.2016.03.030</Citation><ArticleIdList><ArticleId IdType="pubmed">27031595</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawaya H, Atoui M, Hamadeh A, et al. Adaptation and initial validation of the Patient Health Questionnaire &#x2013;9 (PHQ-9) and the Generalized Anxiety Disorder &#x2013;7 Questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample. Psychiatry Research. 2016;239:245&#x2013;252. doi: 10.1016/j.psychres.2016.03.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2016.03.030</ArticleId><ArticleId IdType="pubmed">27031595</ArticleId></ArticleIdList></Reference><Reference><Citation>23. Kroenke K, Spitzer R, Williams J. The PHQ-9. J Gen Intern Med. 2001;16(9):606-613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer R, Williams J. The PHQ-9. J Gen Intern Med. 2001;16(9):606&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>24. Malaeb D, Farchakh Y, Haddad C, et al. Validation of the Beirut Distress Scale (BDS?10), a short version of BDS?22, to assess psychological distress among the Lebanese population. Perspectives in Psychiatric Care. 2022;58(1):304-313.</Citation><ArticleIdList><ArticleId IdType="pubmed">33821486</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaeb D, Farchakh Y, Haddad C, et al. Validation of the Beirut Distress Scale (BDS-10), a short version of BDS-22, to assess psychological distress among the Lebanese population. Perspectives in Psychiatric Care. 2022;58(1):304&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">33821486</ArticleId></ArticleIdList></Reference><Reference><Citation>25. The PTSD Checklist (PCL):Reliability, validity, and diagnostic utility. annual convention of the international society for traumatic stress studies, San Antonio, TX:San Antonio, TX;1993.</Citation></Reference><Reference><Citation>The PTSD Checklist (PCL):Reliability, validity, and diagnostic utility. annual convention of the international society for traumatic stress studies. San Antonio, TX: San Antonio, TX; 1993.</Citation></Reference><Reference><Citation>26. Hallit S, Obeid S, Haddad C, et al. Construction of the Lebanese Anxiety Scale (LAS-10):a new scale to assess anxiety in adult patients. International Journal of Psychiatry in Clinical Practice. 2020;24(3):270-277. https://doi.org/10.1080/13651501.2020.1744662</Citation><ArticleIdList><ArticleId IdType="pubmed">32228282</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallit S, Obeid S, Haddad C, et al. Construction of the Lebanese Anxiety Scale (LAS-10):a new scale to assess anxiety in adult patients. International Journal of Psychiatry in Clinical Practice. 2020;24(3):270&#x2013;277. doi: 10.1080/13651501.2020.1744662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13651501.2020.1744662</ArticleId><ArticleId IdType="pubmed">32228282</ArticleId></ArticleIdList></Reference><Reference><Citation>27. Merhy G, Azzi V, Salameh P, et al. Anxiety among Lebanese adolescents:scale validation and correlates. BMC Pediatr. 2021;21. https://doi.org/10.1186/s12887-021-02763-4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8218523</ArticleId><ArticleId IdType="pubmed">34158020</ArticleId></ArticleIdList></Reference><Reference><Citation>Merhy G, Azzi V, Salameh P, et al. Anxiety among Lebanese adolescents:scale validation and correlates. BMC Pediatr. 2021:21. doi: 10.1186/s12887-021-02763-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-021-02763-4</ArticleId><ArticleId IdType="pmc">PMC8218523</ArticleId><ArticleId IdType="pubmed">34158020</ArticleId></ArticleIdList></Reference><Reference><Citation>28. George D, Mallery P. SPSS for Windows step by step:a simple guide and reference, 17.0 update. 10th ed. ed.:Boston:Allyn &amp;Bacon;2010.</Citation></Reference><Reference><Citation>George D, Mallery P. SPSS for Windows step by step:a simple guide and reference, 17.0 update. 10th ed. ed. Boston: Allyn &amp;Bacon; 2010.</Citation></Reference><Reference><Citation>29. Nabavi N. Long covid:How to define it and how to manage it. BMJ. 2020;370:m3489. https://doi.org/10.1136/bmj.m3489</Citation><ArticleIdList><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid:How to define it and how to manage it. BMJ. 2020;370:m3489. doi: 10.1136/bmj.m3489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>30. Lam MH, Wing Y, Yu MW, et al. Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome Survivors:Longterm Follow-up. Archives of Internal Medicine. 2009;169(22):2142-2147. https://doi.org/10.1001/archinternmed.2009.384</Citation><ArticleIdList><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH, Wing Y, Yu MW, et al. Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome Survivors:Longterm Follow-up. Archives of Internal Medicine. 2009;169(22):2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>31. Ahmed H, Patel K, Greenwood DC, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission:A systematic review and metaanalysis. Journal of Rehabilitation Medicine. 2020;52(5):jrm00063. https://doi.org/10.2340/16501977-2694</Citation><ArticleIdList><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H, Patel K, Greenwood DC, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission:A systematic review and metaanalysis. Journal of Rehabilitation Medicine. 2020;52(5):jrm00063. doi: 10.2340/16501977-2694.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>32. Staudt A, J&#xf6;rres RA, Hinterberger T, et al. Associations of Post-Acute COVID syndrome with physiological and clinical measures 10 months after hospitalization in patients of the first wave. European Journal of Internal Medicine. 2022;95:50-60. https://doi.org/10.1016/j.ejim.2021.10.031</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8612867</ArticleId><ArticleId IdType="pubmed">34838369</ArticleId></ArticleIdList></Reference><Reference><Citation>Staudt A, J&#xf6;rres RA, Hinterberger T, et al. Associations of Post-Acute COVID syndrome with physiological and clinical measures 10 months after hospitalization in patients of the first wave. European Journal of Internal Medicine. 2022;95:50&#x2013;60. doi: 10.1016/j.ejim.2021.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.10.031</ArticleId><ArticleId IdType="pmc">PMC8612867</ArticleId><ArticleId IdType="pubmed">34838369</ArticleId></ArticleIdList></Reference><Reference><Citation>33. Simon, Michael A, Luginbuhl, et al. Reduced Incidence of Long-COVID Symptoms Related to Administration of COVID-19 Vaccines Both Before COVID-19 Diagnosis and Up to 12 Week. 2021.</Citation></Reference><Reference><Citation>Simon , Michael A, Luginbuhl, et al. Reduced Incidence of Long-COVID Symptoms Related to Administration of COVID-19 Vaccines Both Before COVID-19 Diagnosis and Up to 12 Week. 2021</Citation></Reference><Reference><Citation>34. Gaber, Tarek AK, Ashish A, et al. Are mRNA Covid 19 vaccines safe in Long Covid patients?A Health Care Workers perspective. British Journal of Medical Practitioners. 2021;14(1):9. https://doi.org/10.1007/s40278-022-09792-6</Citation></Reference><Reference><Citation>Gaber , Tarek AK, Ashish A, et al. Are mRNA Covid 19 vaccines safe in Long Covid patients?A Health Care Workers perspective. British Journal of Medical Practitioners. 2021;14(1):9. doi: 10.1007/s40278-022-09792-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40278-022-09792-6</ArticleId></ArticleIdList></Reference><Reference><Citation>35. Prevalence, characteristics, and predictors of Long COVID among diagnosed cases of COVID-19. Vaccine Weekly. 2022:146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence, characteristics, and predictors of Long COVID among diagnosed cases of COVID-19. Vaccine Weekly. 2022:146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>36. The effectiveness of vaccination against long COVID A rapid evidence briefing.</Citation></Reference><Reference><Citation>The effectiveness of vaccination against long COVID A rapid evidence briefing</Citation></Reference><Reference><Citation>37. Baker N, Ledford H. Coronapod:vaccines and long COVID, how protected are you?Nature (London). 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34893782</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker N, Ledford H. Coronapod:vaccines and long COVID, how protected are you? Nature (London) 2021</Citation><ArticleIdList><ArticleId IdType="pubmed">34893782</ArticleId></ArticleIdList></Reference><Reference><Citation>38. Bermingham SL, Cohen A, Hague J, et al. The cost of somatisation among the working?age population in England for the year 2008&#x2013;2009. Ment Health Fam Med. 2010;7(2):71-84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2939455</ArticleId><ArticleId IdType="pubmed">22477925</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermingham SL, Cohen A, Hague J, et al. The cost of somatisation among the working-age population in England for the year 2008&#x2013;2009. Ment Health Fam Med. 2010;7(2):71&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2939455</ArticleId><ArticleId IdType="pubmed">22477925</ArticleId></ArticleIdList></Reference><Reference><Citation>39. Hung CI, Yu NW, Liu CY, et al. The impact of the duration of an untreated episode on improvement of depression and somatic symptoms. Neuropsychiatr Dis Treat. 2015;11:2245-2252. https://doi.org/10.2147/ndt.s89498</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4556250</ArticleId><ArticleId IdType="pubmed">26346571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung CI, Yu NW, Liu CY, et al. The impact of the duration of an untreated episode on improvement of depression and somatic symptoms. Neuropsychiatr Dis Treat. 2015;11:2245&#x2013;2252. doi: 10.2147/ndt.s89498.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ndt.s89498</ArticleId><ArticleId IdType="pmc">PMC4556250</ArticleId><ArticleId IdType="pubmed">26346571</ArticleId></ArticleIdList></Reference><Reference><Citation>40. Sancak B, Ozer Agirbas U, Kilic C. Long COVID and Its Psychiatric Aspects. Journal of the Academy of Consultation-Liaison Psychiatry. 2021;62(4):480-481. https://doi.org/10.1016/j.jaclp.2021.03.003</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005382</ArticleId><ArticleId IdType="pubmed">33817685</ArticleId></ArticleIdList></Reference><Reference><Citation>Sancak B, Ozer Agirbas U, Kilic C. Long COVID and Its Psychiatric Aspects. Journal of the Academy of Consultation-Liaison Psychiatry. 2021;62(4):480&#x2013;481. doi: 10.1016/j.jaclp.2021.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaclp.2021.03.003</ArticleId><ArticleId IdType="pmc">PMC8005382</ArticleId><ArticleId IdType="pubmed">33817685</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>